Your browser doesn't support javascript.
loading
Recurrence, postponing pregnancy, and termination rates after hyperemesis gravidarum: Follow up of the MOTHER study.
Nijsten, Kelly; Dean, Caitlin; van der Minnen, Loïs M; Bais, Joke M J; Ris-Stalpers, Carrie; van Eekelen, Rik; Bremer, Henk A; van der Ham, David P; Heidema, Wieteke M; Huisjes, Anjoke; Kleiverda, Gunilla; Kuppens, Simone M; van Laar, Judith O E H; Langenveld, Josje; van der Made, Flip; Papatsonis, Dimitri; Pelinck, Marie-José; Pernet, Paula J; van Rheenen-Flach, Leonie; Rijnders, Robbert J; Scheepers, Hubertina C J; Vogelvang, Tatjana; Mol, Ben W; Roseboom, Tessa J; Koot, Marjette H; Grooten, Iris J; Painter, Rebecca C.
Afiliação
  • Nijsten K; Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Dean C; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Minnen LM; Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bais JMJ; Pregnancy Sickness Support, Bodmin, UK.
  • Ris-Stalpers C; Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Eekelen R; Department of Obstetrics and Gynecology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands.
  • Bremer HA; Laboratory of Reproductive Biology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Ham DP; Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Heidema WM; Department of Obstetrics and Gynecology, Reinier de Graaf Hospital, Delft, the Netherlands.
  • Huisjes A; Department of Obstetrics and Gynecology, Martini Hospital, Groningen, the Netherlands.
  • Kleiverda G; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kuppens SM; Department of Obstetrics and Gynecology, Gelre Hospital, Apeldoorn, the Netherlands.
  • van Laar JOEH; Department of Obstetrics and Gynecology, Flevo Hospital, Almere, the Netherlands.
  • Langenveld J; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands.
  • van der Made F; Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, the Netherlands.
  • Papatsonis D; Department of Obstetrics and Gynecology, Zuyderland Hospital, Heerlen, the Netherlands.
  • Pelinck MJ; Department of Obstetrics and Gynecology, Franciscus Gasthuis, Rotterdam, the Netherlands.
  • Pernet PJ; Department of Obstetrics and Gynecology, Amphia Hospital, Breda, the Netherlands.
  • van Rheenen-Flach L; Department of Obstetrics and Gynecology, Scheper Hospital, Emmen, the Netherlands.
  • Rijnders RJ; Department of Obstetrics and Gynecology, Spaarne Gasthuis, Haarlem, the Netherlands.
  • Scheepers HCJ; Department of Obstetrics and Gynecology, OLVG, Amsterdam, the Netherlands.
  • Vogelvang T; Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Mol BW; Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Roseboom TJ; Department of Obstetrics and Gynecology, Diakonessenhuis, Utrecht, the Netherlands.
  • Koot MH; Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia.
  • Grooten IJ; Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Painter RC; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Acta Obstet Gynecol Scand ; 100(9): 1636-1643, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34033123
ABSTRACT

INTRODUCTION:

Hyperemesis gravidarum (HG) complicates 1% of pregnancies and has a major impact on maternal quality of life and well-being. We know very little about HG's long-term impact after an affected pregnancy, including recurrence rates in future pregnancies, which is essential information for women considering subsequent pregnancies. In this study, we aimed to prospectively measure the recurrence rate of HG and the number of postponed and terminated subsequent pregnancies due to HG. We also aimed to evaluate if there were predictive factors that could identify women at increased risk for HG recurrence, and postponing and terminating subsequent pregnancies. MATERIAL AND

METHODS:

We conducted a prospective cohort study. A total of 215 women admitted for HG to public hospitals in the Netherlands were enrolled in the original MOTHER randomized controlled trial and associated observational cohort. Seventy-three women were included in this follow-up study. Data were collected through an online questionnaire. Recurrent HG was defined as vomiting symptoms accompanied by any of the following multiple medication use, weight loss, admission, tube feeding or if nausea and vomiting symptoms were severe enough to affect life and/or work. Outcome measures were recurrence, postponing, and termination rates due to HG. Univariable logistic regression analysis was used to identify predictive factors associated with HG recurrence, and postponing and terminating subsequent pregnancies.

RESULTS:

Thirty-five women (48%) became pregnant again of whom 40% had postponed their pregnancy due to HG. HG recurred in 89% of pregnancies. One woman terminated and eight women (23%) considered terminating their pregnancy because of recurrent HG. Twenty-four out of 38 women did not get pregnant again because of HG in the past. Univariable logistic regression analysis identifying possible predictive factors found that having a western background was associated with having weight loss due to recurrent HG in subsequent pregnancies (odds ratio 12.9, 95% CI 1.3-130.5, p = 0.03).

CONCLUSIONS:

High rates of HG recurrence and a high number of postponed pregnancies due to HG were observed. Women can be informed of a high chance of recurrence to enable informed family planning.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Hiperêmese Gravídica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Acta Obstet Gynecol Scand Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Hiperêmese Gravídica Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Acta Obstet Gynecol Scand Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda